Adient swings to $335 million Q2 loss on $333 million goodwill impairment
Adient reported a net loss attributable to Adient of $335 million, or $3.99 per diluted share, for the quarter ended March 31, 2025, compared with a loss of $70 million, or $0.77 per share, a year earlier. Net sales fell to $3.61 billion from $3.75 billion, and restructuring and impairment costs rose to $351 million, including a $333 million goodwill impairment. Adjusted diluted earnings per share rose to $0.69 from $0.54, so shareholders face a larger reported loss alongside higher adjusted profit.
Key points
- Net sales were $3.61 billion, down from $3.75 billion a year earlier.
- Net loss attributable to Adient was $335 million, or $3.99 per diluted share, versus $70 million, or $0.77 per share.
- Adjusted diluted earnings per share were $0.69, up from $0.54; adjusted EBITDA was $233 million, up from $227 million.
- Cash used by operating activities was $45 million, and net debt was $1.64 billion at March 31, 2025.
The filing
Written by AI on Nov 8, 2026, 6:59 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 07, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.